6. Glycemic Targets: Standards of Medical Care in Diabetes—2021
The DOI matches its Crossref record; 117 of the 118 references it cites were found in a registry or an index.
Abstract
The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc21-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc21-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These findings have informed clinical practice guidelines and policy, which now recommend that SMBG not be used routinely in this group (21–26).”
In the citing paper
“While the drug manufacturer is currently offering a savings card program for some patients for whom pricing is a barrier, payor coverage for tirzepatide will likely be a barrier to patient use, especially before tirzepatide has been officially recognized as a standard of care in professional guidelines. 2”
From Tirzepatide: Clinical review of the twincretin injectable (2023) · cites this paper as [2]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · cited 2×
“33% with metformin as initial pharmacotherapy) and in all-cause mortality (13% and 27%, respectively) (33).”
BackgroundIntensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
Research works printed but not linked: 1
- Dicembrini, Impact of technology on glycemic control in type 2 diabetes: a meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion, Diabetes Obes Metab
Cited by
Items 201–300 of 846
Ballesta, S., Chillarón, J. J., Inglada, Y., Climent, E., Llauradó, G., Pedro‐Botet, J., Cots, F., Camell, H., Roux, J. A. F., & Benaiges, D. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1176765 · Cited by 17
Ram, Y., Xu, Y., Cheng, A., Dunn, T. C., & Ajjan, R. (2024) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2023-003470 · Cited by 21
Mittal, R., Koutras, N., Maya, J., Lemos, J. R. N., & Hirani, K. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1352302 · Cited by 19
The impact of diabetes on heart failure development: The cardio-renal-metabolic connection
Valensi, P. E., Prévost, G., Pinto, S., Halimi, J., & Donal, E. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108831 · Cited by 20
Tanenbaum, M. L., Ngo, J., Hanes, S. J., Basina, M., Buckingham, B. A., Hessler, D., Maahs, D. M., Mulvaney, S. A., & Hood, K. K. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0198 · Cited by 19
Glycaemic variabilities: Key questions in pursuit of clarity
Monnier, L., Owens, D. R., Colette, C., & Bonnet, F. (2021) · Diabetes & Metabolism · doi:10.1016/j.diabet.2021.101283 · Cited by 16
Larsen, K. L., Akindele, B., Head, H., Evans, R., Mehta, P., Hlatky, Q., Krause, B., Chen, S., & King, D. (2021) · JMIR Human Factors · doi:10.2196/33470 · Cited by 18
Bretschneider, M. P., Kolasińska, A. B., Šomvárska, L., Klásek, J., Mareš, J., & Schwarz, P. E. (2025) · Journal of Medical Internet Research · doi:10.2196/68648 · Cited by 23
Wijk, I., Amsberg, S., Johansson, U.-B., Livheim, F., Toft, E., & Anderbro, T. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-072061 · Cited by 15
“A 4-point Likert scale, starting with didn’t apply to me at all and ending with applied to me very much or most of the time, is used for rating.”
The Influence of Health Mindset on Perceptions of Illness and Behaviors Among Adolescents
John‐Henderson, N. A., Wright, R. C., Manke, K. J., Fotuhi, O., ZUCKERMAN, B. S., Nally, L. M., & Mueller, C. M. (2021) · International Journal of Behavioral Medicine · doi:10.1007/s12529-021-09972-2 · Cited by 18
Wu, F., Chen, Y., Navas‐Acién, A., Garabedian, M. L., Coates, J., & Newman, J. D. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18073749 · Cited by 15
Choi, I. J., Choo, E. H., Kim, H. J., Lim, S., Moon, D., Lee, K. Y., Hwang, B., Kim, C. J., Park, M., Lee, J. M., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01428-x · Cited by 18
Impact of My Dose Coach App Frequency of Use on Clinical Outcomes in Type 2 Diabetes
Unnikrishnan, A., Viswanathan, V., Zhou, F. L., Hao, L., Kamath, P., Bertolini, M., Botero, J. F., & Mancillas‐Adame, L. G. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01245-9 · Cited by 18
Ito, A., Matsui, Y., Takeshita, M., Katashima, M., Goto, C., & Kuriki, K. (2023) · Archives of Microbiology · doi:10.1007/s00203-023-03522-y · Cited by 19
Yamamoto, Y., Narumi, K., Yamagishi, N., Nishi, T., Ito, T., Iseki, K., Kobayashi, M., & Kanai, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1197743 · Cited by 17
Fløde, M., Hermann, M., Haugstvedt, A., Søfteland, E., Igland, J., Åsberg, A., Jenssen, T. G., & Graue, M. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01472-6 · Cited by 15
Adu, F., Poku, C. A., Adu, A., & Owusu, L. B. (2024) · Health Science Reports · doi:10.1002/hsr2.2054 · Cited by 24
GILL, A. K., Gothard, M. D., & Early, K. B. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002564 · Cited by 17
How use of continuous glucose monitoring can address therapeutic inertia in primary care
Martens, T. W., & Parkin, C. G. (2022) · Postgraduate Medicine · doi:10.1080/00325481.2022.2080419 · Cited by 16
Prevalence of oral lichen planus in patients with diabetes mellitus: A cross‐sectional study
Sun, Y., Chen, D., Deng, X., Xu, Y., Wang, Y., Qiu, X., Yuan, P., Zhang, Z., Xu, H. Y., & Jiang, L. (2022) · Oral Diseases · doi:10.1111/odi.14323 · Cited by 19
Liu, M., Liu, C., Lin, T.-C., & Ma, Y. (2023) · Bioengineering · doi:10.3390/bioengineering10101139 · Cited by 20
Ling, S., Sweeting, M. J., Zaccardi, F., Adlam, D., & Kadam, U. T. (2022) · BMC Cancer · doi:10.1186/s12885-022-10144-y · Cited by 14
Suh, J., Choi, Y., Oh, J. S., Song, K., Choi, H. S., Kwon, A., Chae, H. W., & Kim, H.-S. (2023) · Primary care diabetes · doi:10.1016/j.pcd.2022.12.006 · Cited by 17
Chen, Y., Chen, Z., Zhao, L., Li, S., Ying, Z., Yu, P., Yan, H., Chen, H., Yang, C., Zhang, J., et al. (2023) · Current Medicine · doi:10.1007/s44194-023-00020-7 · Cited by 21
“In our study, coefficient of variation of blood glucose was improved to 25.2% at day 4 and to 20.1% at day 7, which was lower than the threshold recommended by the ADA guideline (American, 2021).”
BackgroundInfluentialSong, Y., Zhao, Y. J., Bai, X., Cheng, W., Wang, L., Shu, M., Shu, Y., Zhang, L., & Jin, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1111152 · Cited by 15
Antoniak-Pietrynczak, K., Zorena, K., Jaskulak, M., Hansdorfer-Korzon, R., & Koziński, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210338 · Cited by 16
Frazer, M., Swift, C., Gronroos, N. N., Sargent, A., Leszko, M., Buysman, E. K., Alvarez, S., Dunn, T. J., Noone, J. M., & Guevarra, M. (2023) · Advances in Therapy · doi:10.1007/s12325-023-02677-w · Cited by 19
“In most patients, an HbA1c goal of \ 7% is sought given the benefits of reducing or preventing diabetes-related complications; however, an HbA1c goal of \ 8% in some patients may be necessary to balance these benefits with the risk of hypoglycemia [5, 6].”
Intermittent fasting in the management of diabetes: a review of glycemic control and safety
Santos, H. O. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad132 · Cited by 15
Lauffenburger, J. C., Tesfaye, H., Solomon, D. H., Antman, E. M., Glynn, R. J., Lee, S. B., Tong, A., & Choudhry, N. K. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-075840 · Cited by 19
Liu, D., Zhang, Y., Wu, Q., Han, R., Cheng, D., Wu, L., Guo, J., Yu, X., Ge, W., Ni, J., et al. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.13549 · Cited by 19
“6 Low-carbohydrate diets can improve glucose homeostasis in people with obesity, with decline in serum glycated albumin, MSG, and CV. 31 During the study period, we required all participants to prepare and consume their meals according to the Dietary Guidelines for Chinese Residents.”
MethodAhmed, M., Shafiq, A., Javaid, H., Jain, H., Nashwan, A. J., Tul‐Ain, Q., & Basit, J. (2024) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.480 · Cited by 16
Remission of type 2 diabetes after gastrectomy for gastric cancer: diabetes prediction score
Kwon, Y., Kwon, J., Ha, J., Kim, D., Cho, J., Jeon, S. M., Park, S., Hwang, J., Kim, N. H., & Park, S. S. (2021) · Gastric Cancer · doi:10.1007/s10120-021-01216-2 · Cited by 17
Diabetes: how to manage patients experiencing hypoglycaemia
Lowe, R. N., Williams, B., & Claus, L. W. (2022) · Drugs in Context · doi:10.7573/dic.2021-9-11 · Cited by 27
Timoteo, V. J., Chiang, K.-M., & Pan, W.-H. (2022) · Nutrients · doi:10.3390/nu14194007 · Cited by 13
Cucinotta, D., Nicolucci, A., Giandalia, A., Lucisano, G., Manicardi, V., Mannino, D., Rossi, M. C., Russo, G. T., & Bartolo, P. D. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109096 · Cited by 15
Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes
Schnell, O., Battelino, T., Bergenstal, R. M., Blüher, M., Böhm, M., Brosius, F. C., Carr, R. D., Ceriello, A., Forst, T. M., Giorgino, F., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01481-0 · Cited by 17
AlQuadeib, B. T., Aloudah, N. M., Almurshedi, A. S., Alfagih, I. M., Aldosari, B. N., ALmeleky, A. S., & Almubyedh, N. M. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s312633 · Cited by 13
Hepatogenous Diabetes - A Report from Central India
Vasepalli, P., Noor, M. T., & Thakur, B. S. (2021) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2021.08.018 · Cited by 15
Engström, M. S., Johansson, U., Leksell, J. K., Linder, E., & Eeg‐Olofsson, K. (2022) · JMIR Diabetes · doi:10.2196/34561 · Cited by 14
The Role of Platelets in Hypoglycemia-Induced Cardiovascular Disease: A Review of the Literature
Ali, A. A. G., Niinuma, S. A., Moin, A. S. M., Atkin, S. L., & Butler, A. E. (2023) · Biomolecules · doi:10.3390/biom13020241 · Cited by 14
Zhao, L., Zhou, X., Chen, Y., Dong, Q., Zheng, Q., Wang, Y., Li, L., Zhao, D., Ji, B., Xu, F., et al. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13463 · Cited by 13
Sagris, D., Ntaios, G., & Milionis, H. J. (2023) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2022-329149 · Cited by 13
“19 50 51 Due to the lack of dedicated or large randomized controlled trials (RCTs) of classic antidiabetic drugs such as metformin or other old antidiabetic drugs in patients with ischaemic stroke, there is no compelling evidence on their effectiveness.”
BackgroundYu, A., Truong, Q., Whitfield, K., Hale, A., Taing, M., Barker, N., & D’Emden, M. (2024) · Diabetic Medicine · doi:10.1111/dme.15380 · Cited by 13
“%) recommended for most non-pregnant adults 10,11 to reduce risk of microvascular complications.”
Li, Y., Pan, T., Wang, L., Wang, Y., Gong, Y., Wang, G., & Zhang, Q. (2024) · Scientific Reports · doi:10.1038/s41598-024-76074-w · Cited by 14
“Hemoglobin A1c (HbA1c) is a predictive factor of the development of diabetes complications 11 , but could not reflect glycemic variability.”
BackgroundAssociation of Prestroke Glycemic Control With Vascular Events During 1-Year Follow-up
Chang, J. Y., Kim, W., Kwon, J. H., Lee, J. S., Kim, B. J., Kim, J., Lee, J., Cha, J., Kim, D., Cho, Y., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012729 · Cited by 14
Importance of diabetes management during the COVID-19 pandemic
Pettus, J., & SKOLNIK, N. (2021) · Postgraduate Medicine · doi:10.1080/00325481.2021.1978704 · Cited by 17
Cha, S., Yun, J., Kim, G.-H., & Ahn, Y. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01651-0 · Cited by 17
Tirzepatide: Clinical review of the twincretin injectable
Krauss, Z., Hintz, A., & Fisk, R. (2023) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxad080 · Cited by 12
Disparities in HbA1c testing between aging US Latino and non-Latino white primary care patients
Aceves, B., Ezekiel-Herrera, D., Marino, M., Datta, R., Lucas, J., Giebultowicz, S., & Heintzman, J. D. (2022) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2022.101739 · Cited by 15
Classification Model for Diabetic Foot, Necrotizing Fasciitis, and Osteomyelitis
Kim, J., Yoo, G., Lee, T., Kim, J. H., Seo, D. M., & Kim, J. (2022) · Biology · doi:10.3390/biology11091310 · Cited by 13
Research progress in the application of time in range: more than a percentage
Wan, J., Lu, J., Li, C., Ma, X., & Zhou, J. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002582 · Cited by 12
Determinants of hypertension among diabetic patients in southern Ethiopia: a case-control study
Anjajo, E. A., Workie, S. B., Tema, Z. G., Woldegeorgis, B. Z., & Bogino, E. A. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03245-4 · Cited by 21
Differential correlation between time in range and eGFR or albuminuria in type 2 diabetes
Jin, X., Yang, X., Xu, Y., Liang, J., Liu, C., Guo, Q., Wang, W., Feng, Z., Yuan, Y., Zhou, H., et al. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01071-4 · Cited by 15
Yoon, S.-Y., Kim, J. S., Ko, G. J., Choi, Y., Moon, J.-Y., Jeong, K. H., & Hwang, H. S. (2024) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.23.098 · Cited by 14
“Consequently, HD patients often maintain higher FBG levels in adherence to these recommendations [11,20].”
BackgroundHamidi, H., Bagheri, M., Benzing, T., Krishnan, S., Kianoush, S., Ichikawa, K., Ghanem, A. K., Javier, D., Iskander, B., Aldana-Bitar, J., et al. (2024) · American Heart Journal · doi:10.1016/j.ahj.2024.08.015 · Cited by 14
Chatwin, H., Broadley, M. M., Hendrieckx, C., Carlton, J., Heller, S. R., Amiel, S. A., de Galan, B. E., Hermanns, N., Finke-Gröne, K., Speight, J., et al. (2021) · Diabetic Medicine · doi:10.1111/dme.14727 · Cited by 13
Liao, P.-Y., Lo, H., Liu, I.-C., Lo, L.-C., Hsiang, C., & Ho, T. (2021) · Food & Function · doi:10.1039/d1fo03620c · Cited by 12
Márkus, B., Hargittay, C., Iller, B., Rinfel, J., Bencsik, P., Oláh, I., Kalabay, L., & Vörös, K. (2022) · BMC Family Practice · doi:10.1186/s12875-021-01615-5 · Cited by 18
Takebayashi, K., Yamauchi, M., Hara, K., Tsuchiya, T., & Hashimoto, K. (2022) · Diabetology International · doi:10.1007/s13340-022-00574-1 · Cited by 12
Hsu, W.-C., Lin, C., Chen, J., & Chang, C. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092653 · Cited by 14
Continuous glucose monitoring to assess glucose variability in type 3c diabetes
Lee, V. T. Y., Poynten, A. M., & Depczynski, B. (2022) · Diabetic Medicine · doi:10.1111/dme.14882 · Cited by 17
Farhan, H., Bukhari, K., Grewal, N., Devarasetty, S., & Munir, K. M. (2022) · BMJ Case Reports · doi:10.1136/bcr-2021-248579 · Cited by 15
Pagano, F., Picchio, V., Bordin, A., Cavarretta, E., Nocella, C., Cozzolino, C., Floris, E., Angelini, F., Sordano, A., Peruzzi, M., et al. (2022) · The Journal of Pathology · doi:10.1002/path.5985 · Cited by 12
Zaharieva, D. P., Addala, A., Prahalad, P., Leverenz, B., Arrizon‐Ruiz, N., Ding, V. Y., Desai, M., Karger, A. B., & Maahs, D. M. (2022) · Diabetology · doi:10.3390/diabetology3030037 · Cited by 12
Mehrabbeik, A., Namiranian, N., Azizi, R., Meybody, M. A., Shariati, M., & Kohani, H. A. M. (2022) · Intern J Endocrinol Metab · doi:10.5812/ijem-128392 · Cited by 14
Dholariya, S. J., Dutta, S., Singh, R., Parchwani, D. N., Sonagra, A. D., & Kaliya, M. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2269854 · Cited by 18
“Therefore, bexagliflozin 20 mg could be a promising therapeutic candidate in getting the HbA1c target of 7% as per standard medical care of the American Diabetes Association (ADA) [43].”
MethodFrías, J. P., Bonora, E., Ruiz, L. N., Hsia, S. H., Jung, H., Raha, S., Cox, D. A., Bethel, M. A., & Кониг, М. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14469 · Cited by 11
Endovascular Celiac Denervation for Glycemic Control in Patients with Type 2 Diabetes Mellitus
Pan, T., Li, L., Wei, Q., Wang, Z., Zhang, Q., Qian, Y., Li, R., Liu, D., Wang, Y., Sun, Z., et al. (2021) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2021.07.023 · Cited by 12
Kamath, S., Kappaganthu, K., Painter, S. L., & Madan, A. (2022) · JMIR Formative Research · doi:10.2196/33329 · Cited by 12
Chiang, Y., Chang, C., Yu, H., Tsay, P., Lo, F., Chen, C., Lin, W., Hsu, C., An, C., & Moons, P. (2022) · Nursing Open · doi:10.1002/nop2.1432 · Cited by 11
“Reports indicate that 75% of adolescents and 69% of parents would use mobile applications to control type 1 diabetes (Barnes et al., 2018).”
BackgroundYeom, J. W., Kholinne, E., Kim, D. M., Lee, J.-B., Ben, H., AlAhmadi, B. M., Shin, M. J., Kim, M., Park, J. H., Koh, K. H., et al. (2023) · Orthopaedic Journal of Sports Medicine · doi:10.1177/23259671221145987 · Cited by 11
Wang, Y., Lu, J., Ni, J., Wang, M., Shen, Y., Lu, W., Zhu, W., Bao, Y., & Zhou, J. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3639 · Cited by 12
Trends in diabetes incidence in Austria 2013–2017
Kaleta, M., Leutner, M., Stefan Thurner, A., Endel, G., Kiss, N., Robausch, M., Klimek, P., & Kautzky‐Willer, A. (2023) · Scientific Reports · doi:10.1038/s41598-023-35806-0 · Cited by 14
Toyoshima, M. T. K., Cukier, P., Damascena, A. S., Batista, R. L., Correa, F. A., Kawahara, E. Z., Minanni, C. A., Hoff, A. O., & Nery, M. (2023) · Clinics · doi:10.1016/j.clinsp.2023.100240 · Cited by 17
Afshari, N., Hashemi, S. M., & Geran, F. (2023) · IET Microwaves Antennas & Propagation · doi:10.1049/mia2.12404 · Cited by 11
Su, P., & Liu, K. (2024) · Displays · doi:10.1016/j.displa.2024.102664 · Cited by 12
State Out-Of-Pocket Caps On Insulin Costs: No Significant Increase In Claims Or Utilization
Anderson, K. E., Chaiyakunapruk, N., Gutierrez, E. J., Schmutz, H. W., Rose, M. R., Brixner, D. I., & McQueen, R. B. (2024) · Health Affairs · doi:10.1377/hlthaff.2024.00118 · Cited by 15
Batir, D. M., Ștefan, C. S., Boev, M., Gurău, G., Popa, G. V., Matei, M. N., Ursu, M., Nechita, A., & Maftei, N.-M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14072144 · Cited by 14
“Inadequate management during this transition signifi ‐ cantly increases the risk of severe hypoglycemia, which may lead to seizures, diabetic ke ‐ toacidosis, and comas, potentially resulting in neurological damage or even fatal conse ‐ quences [68].”
van Baar, A. C. G., Meiring, S., Holleman, F., Hopkins, D., Mingrone, G., Deviere, J. M. E., Nieuwdorp, M., & Bergman, J. J. G. H. M. (2021) · Gut · doi:10.1136/gutjnl-2020-323931 · Cited by 13
Choi, M. S., Lee, S., Kim, J., Kim, G., Park, S., & Kim, J. H. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0011 · Cited by 15
Strenth, C. R., Mo, A., Kale, N. J., Day, P. G., Gonzalez, L., Green, R., Cruz, I. I., & Schneider, D. (2022) · Journal of Interpersonal Violence · doi:10.1177/08862605221076536 · Cited by 10
HbA1c , blood pressure, and cholesterol control in adults with diabetes: A report card for Kuwait
Alkandari, A., Gujral, U. P., Bennakhi, A., Qabazard, S., Al‐Wotayan, R., Al-Duwairi, Q., Alkandari, H., Narayan, K. V., & Alarouj, M. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13832 · Cited by 12
Snoek, F. J., Spaepen, E., Nambu, B. A., Child, C. J., Bajpai, S., Balantac, Z., Bushnell, D. M., Pokrzywinski, R. M., & Mitchell, B. D. (2022) · Clinical Diabetes · doi:10.2337/cd21-0131 · Cited by 12
Cherni, I., Nakkach, M., Ghalila, H., Nouir, R., Somai, M., Daoued, F., Rachdi, I., BOUSSEMA, F., Jaidane, N.-E., & Hamzaoui, S. (2022) · Instrumentation Science & Technology · doi:10.1080/10739149.2022.2080705 · Cited by 12
Soeholm, U., Broadley, M., Divilly, P., Zaremba, N., Nefs, G., Carlton, J., Mader, J., Baumann, P., Gomes, M., Martine‐Edith, G., et al. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.2525.abstracts · Cited by 11
Zhou, J., Chen, S., Cheng, J., Zhu, J., Lou, Y., Bao, Y., & Jia, W. (2022) · 中国科学通报:英文版 · doi:10.1016/j.scib.2022.08.002 · Cited by 13
Classification of Hypoglycemic Events in Type 1 Diabetes Using Machine Learning Algorithms
Cederblad, L., Eklund, G., Vedal, A., Hill, H., Caballero-Corbalán, J., Hellman, J., Abrahamsson, N., Johnsson, I. W., Carlsson, P., & Espes, D. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01403-7 · Cited by 11
Lubaki, J.-P. F., Omole, O. B., & Francis, J. M. (2023) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2023.1241882 · Cited by 11
Spontaneous and iatrogenic hypoglycemia in cystic fibrosis
Hicks, R. A., Marks, B. E., Oxman, R., & Moheet, A. A. (2021) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2021.100267 · Cited by 15
Bailey, N. C., Dimsits, J., Hammer, M., Kendall, D. M., & Bailey, T. S. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0367 · Cited by 12
Conception by fertility treatment and cardiometabolic risk in middle childhood
Yeung, E. H., Mendola, P., Sundaram, R., Lin, T.-C., Broadney, M. M., Putnick, D. L., Robinson, S. L., Polinski, K. J., Wactawski‐Wende, J., Ghassabian, A., et al. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.04.030 · Cited by 13
Shea, B., Bakre, S., Carano, K., Scharen, J., Langheier, J., & Hu, E. A. (2021) · JMIR Diabetes · doi:10.2196/32298 · Cited by 10
Carreira, A. S., Castro, P., Mira, F. S., Melo, M., Ribeiro, P., & Santos, L. D. C. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02112-0 · Cited by 12
Çetik, R. M., Azboy, İ., Birinci, M., Öztürkmen, Y., Kalyenci, A. S., & Atılla, B. (2023) · Acta Orthopaedica et Traumatologica Turcica · doi:10.5152/j.aott.2023.23037 · Cited by 10
Management of Diabetes in Pregnancy: A Review of Clinical Guidelines and Practices
Albairmani, R. A., Basheer, B., Macky, M. M., Syouti, T. A., AlZubaidy, H., Elfaki, E., Kidwai, A., Basheer, Y. M., Ahmed, F., & Salaheldin, M. (2025) · Cureus · doi:10.7759/cureus.79334 · Cited by 28
“It must be noted that early pregnancy hyperglycemia is associated with an increased risk of congenital malformations, while hyperglycemia later in pregnancy results in fetal overgrowth (macrosomia) and other complications such as shoulder dystocia during delivery [18].”
Stuckey, H. L., Desai, U. S., King, S. B., Popadic, L., Levinson, W., Kirson, N. Y., Hankosky, E. R., & Mitchell, B. D. (2021) · Diabetic Medicine · doi:10.1111/dme.14745 · Cited by 10
Home Telemonitoring of Patients With Type 2 Diabetes: A Meta-Analysis and Systematic Review
Zhu, X., Williams, M., Finuf, K., Patel, V., Sinvani, L., Wolf-Klein, G., Marziliano, A., Nouryan, C., Makaryus, A., Zeltser, R., et al. (2022) · Diabetes Spectrum · doi:10.2337/ds21-0023 · Cited by 10
Alkhatib, N. S., Almutairi, A. R., Alkhezi, O. S., Alfayez, O. M., Yami, M. S. A., & Almohammed, O. A. (2022) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2022.01.018 · Cited by 11
“These two targets were recommended by the American Diabetes Association (ADA) (American Diabetes Association, 2021) and the American Association of Clinical Endocrinologists (AACE) (Garber et al., 2020).”
Hansen, T., Gangal, A., Hijab, E., Barrett, D., Yeung, H., Cao, Y., Switchenko, J. M., & Blalock, T. W. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.17986 · Cited by 12
Laugesen, C., Ranjan, A. G., Schmidt, S., & Nørgaard, K. (2022) · Diabetes Care · doi:10.2337/dc21-2304 · Cited by 13
Metadata
- Authors
- American Diabetes Association
- Corresponding author
- American Diabetes Association
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2020-12-04
- Volume
- 44
- Issue
- Supplement_1
- Pages
- S73-S84
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4236126199
- Cited by
- 847
- References
- 118
- Citations by year
- 2026: 43 · 2025: 80 · 2024: 115 · 2023: 156 · 2022: 265 · 2021: 187 · 2020: 1
- FWCI
- 23.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- glycemic targets, diabetes management, clinical guidelines, quality of care, level of evidence, treatment goals
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Endocrinology, Humans, Societies, Medical, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.